Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Jun Watanabe being referenced
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
2018
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jun Watanabe | 202 | 152 | 90 | 35 | 454 | |
| Guo‐Hao Huang | 199 | 123 | 24 | 33 | 435 | |
| Enrico Pegolo | 85 | 113 | 43 | 46 | 489 | |
| Luigi Tomao | 172 | 63 | 39 | 21 | 383 | |
| Collin M. Labak | 180 | 95 | 59 | 34 | 496 | |
| Michael Müther | 50 | 163 | 60 | 36 | 379 | |
| Sucheta Vaidya | 107 | 74 | 137 | 39 | 402 | |
| Masahito Katoh | 143 | 104 | 135 | 29 | 373 | |
| Yuhua Feng | 198 | 51 | 55 | 25 | 413 | |
| Qingsheng Xu | 193 | 41 | 39 | 29 | 397 | |
| Michael F. Guerrera | 167 | 73 | 77 | 29 | 508 |
All Works
Login with ORCID to disown or claim papers
Loading papers...